Humans are outpacing their own evolution. As scientific advancements accumulate, it can be easy to retreat to the comfort of “the science” or “the data,” overlooking our agency in shaping societal and ethical choices. The path forward demands not only technical progress, and also conscious stewardship.

Note: mostly written in 2017, with light edits over the years, published in 2025 as part of my open archives project — sharing work that has only grown more relevant with time.

We cannot predict what lies ahead for neurotech. It may usher in transformative breakthroughs, present serious ethical challenges, or fall short of its promised potential. What remains certain is that the opportunity to improve countless lives compels us to proceed — boldly yet thoughtfully, with equal measures of determination and responsibility as we navigate this emerging frontier.

In 2015, Brian Harris and Owen McCarthy founded MedRhythms after discovering music’s potential to help people recover from neurological injuries. Brian had implemented effective music-based interventions for language, movement, and cognition recovery at Spaulding Rehabilitation Hospital. Collaborating with Owen, they realized they could transform these clinical approaches into algorithms and software.

Their musically-derived technology had wide-ranging applications, as music could target different parts of the brain with precision. Beyond repair, it could enhance neuroplasticity and essentially rewire brain function. Using software and remote wearables, they envisioned a world where they could reach patients anywhere. After securing venture capital funding, MedRhythms was off to the races.

Editor’s note in 2025: Over the past decade, the company has achieved remarkable success, including FDA Breakthrough Device designation, approval as a primary endpoint in a clinical trial, 12 peer-reviewed publications, and Medicare approval with a dedicated reimbursement code.

MedRhythms is among the pioneers in what would become known as digital therapeutics (DTx), part of the global “software as a medical device” (SaMD) sector regulated by organizations like the FDA’s Digital Health Unit. These technologies are increasingly being adopted as interventions alongside pharmaceutical drugs and traditional medical devices.

The Past: Discovering Our Plastic Brain

“Plasticity” is a common term to those who follow neurotechnology, but we may take for granted how new of a concept it is. The early 20th century was dominated by the belief that brain structure was fixed after childhood development. Santiago Ramón y Cajal, despite his pioneering work on neurons, famously stated in 1928 that “the nerve paths are something fixed, ended, immutable.” Donald Hebb’s 1949 work on synaptic plasticity (often summarized as “neurons that fire together, wire together”) laid crucial theoretical groundwork. The term “neuroplasticity” itself began appearing in scientific literature in the 1960s and 1970s.

Now, the prevailing view in neuroscience is that our brains are far more “plastic” than we formerly believed.

Neuroplasticity is the capacity for continuous alterations of the neural pathways and synapses of the living brain and nervous system in response to experience or injury (NIH).

Neuroplasticity and the ability to alter the brain isn’t inherently good — it can produce both learning and unlearning outcomes for a human. Yes, we could use plasticity to improve measures like learning rates, but also knowledge could be lost by destabilizing a system and artificially modulating plasticity [editor’s note: thanks for Dan Goodwin and Sebastian Seung for this observation]. Every day, scientists are building a stronger understanding of how to control and influence those outcomes.

In the 1960s, Paul Bach-y-Rita was one of the first to seriously study the idea of neuroplasticity when he treated patients with neurological disabilities using sensory substitution. In the 1970s, Mark Rosenzweig (UC Berkeley) and Michael Merzenich (UCSF) started to uncover that experience and activity can change the brain’s circuitry. In the past 50 years, a number of scientists and researchers have made great strides in understanding how to view, image, repair, reorganize and improve the brain.

The Now: Transitioning from nature-directed evolution towards a human-directed one

The communities that research and study the brain have started to diverge. In the US, we have a mature set of institutions that focus on how to decrease the rate of brain disorders and disease in our society (e.g., NIMH). On the other side, we also have another set of institutions that are aiming to accelerate human augmentation and enhancement (e.g., DARPA, IARPA).

Let’s start with brain disorders. The technologies that we have in our toolkit to handle brain disorders are becoming more robust. Neuromodulation, the ability to stimulate portions of the nervous system, has already made great advances in decreasing the rates of Parkinson’s and treatment-resistant depression. Digital therapeutics, which could scale up as wide and as fast as the internet, are on the rise. Boston-based Akili Interactive Labs is developing clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Soon, a patient with pediatric attention-deficit/hyperactivity disorder may be prescribed non-drug treatment — an iPad with Akili’s EndeavorRx therapy — rather than a pill like Adderall or Ritalin. [Note: by 2020 Akili’s EndevorRx got FDA clearance.]

In 2013, the White House launched the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, which straddles both communities. The goal of the initiative is to (a) understand the brain better to both (b) enhance human potential and decrease the rate of disorders.

BRAIN Initiative funds are already accelerating technological development. Additionally, many private companies are starting to invest in enhancing human potential. In 2017, a series of high-profile companies like Bryan Johnson’s Kernel, Elon Musk’s Neuralink, and Facebook’s F8 were seeking to better harness and adapt the brain’s power.

Although we won’t know which companies and initiatives will be successful in the long-term, having access to funds and the best research minds is already advancing the field faster.

The Future: Let’s build a future we want; not an accidental one.

Let’s dive into some of the questions that we’ll likely face over the next few decades. In the past, it was likely tempting to leave the ethical discussions to experts or regulators. But technology is moving faster than our political and legislative systems can proactively handle, especially for topics that are not accessible to the general public. This puts enormous pressure on both businesses, consumers and philanthropy to decide what type of world we want to live in.

This means that it will be important for a greater number of members in our society to form an opinion on what this future should look like. Because if you don’t, someone will take a stand on your behalf.

How do we define “normal” in brain science / mental health?

We use lots of phrases to describe the brain and most are filled with charged connotations. In our society, helping something get back to normal is considered to be a good thing, but often helping someone advance beyond normal is deemed “bad.”

For example, if someone is diagnosed with schizophrenia, our society generally will seek to find a way to provide life-long treatment. On the flip side, we are more cautious about how we handle human advancement. We want to help their children perform well in school and score above average on tests, but there are limits to how we get there. If a child is diagnosed with ADHD, then prescriptions are OK. Without a diagnosis, is it ethical to take Adderall? What’s the boundary to take the pill or not? Learning where to draw the lines is a life-long exercise, and those lines are regularly re-drawn (related: the Overton window).

Our current medical system for brain-related disorders often use a binary classification for the end-state diagnosis:

Some of the criteria can change depending on severity (e.g., major depressive disorder, MDD)- though a diagnosis or not is binary. There are a few conditions, like Autism, that have a spectrum based classification.

These binary descriptions are intimidating. Once someone is a “yes” are they always a yes? Does that “yes” linger with them for ages after symptoms no longer display? What if there is no biomarker?

Perhaps we have a binary classification because it is easier to code it in a medical system, but really all of these classification seem to be sliding scales.

It doesn’t have to be a binary classification. Thomas Insel, former NIMH Director and then at Google Verily, was one of the pioneers of the Research Domain Criteria (RDoC) system. RDOC is an experimental approach to the classification of mental disorders that incorporates multiple dimensions: behavior, thought patterns, neurobiological measures, and genetics. This means that every classification is more of a sliding scale than a binary “yes/no” based on limited outcomes.

As a society, even if we have the language for the brain-related outcomes we’d like to achieve, how do we think about classifying states of the brain? “Mental health” is often used in situations where someone has a deficiency compared to a standard of “normal.” Human augmentation is for some a Silicon Valley dream and for others a scary, science-fiction nightmare.

But what and who truly defines this “normal” state of the brain? How will it change over time?

Will we need to rethink “human rights”?

Marcello Ienca and Roberto Andorno from the Institute for Biomedical Ethics at the University of Zurich, Switzerland posit that we will need to rethink rights in a new paper, published in Life Sciences, Society and Policy. They posit:

In the play Comus, written by John Milton in 1634, a young noblewoman is abducted by a sorcerer named Comus and bounded to an enchanted chair. Despite being restrained against her will, the woman repeatedly refuses Comus’ advances and claims “Thou canst not touch the freedom of my mind”, confident of her capacity to protect her mental freedom from any external manipulation. This idea of the human mind as the ultimate domain of absolute protection from external intrusion has been increasingly outdated by advances in neuroscience and neurotechnology.

In the piece, the autors posit that the advances in neurotechonology to image, repair, and improve the brain pose a fundamental ethical, legal, and social challenge: “determining whether, or under what conditions, it is legitimate to gain access to or to interfere with another person’s neural activity.”

They advocate for a “reconceptualization of existing human rights” and, perhaps, a creation of “new human rights” that they call “neurorights”:

Neurorights: the right to cognitive liberty, the right to mental privacy, the right to mental integrity, and the right to psychological continuity.

Cognitive liberty is not something we can take for granted anymore. For example, with the rise of deep brain stimulation, we’ve been able to reverse the symptoms of Parkinson’s by altering the circuits of the brain. Or MDMA-assisted therapy for moderate to severe PTSD. But those circuits will also be accessible to malevolent actors.

Mental privacy aims to “protect individuals against unconsented intrusion by third parties.” The authors note that Steven Spielberg’s Minority Report scenario has become an increasingly real risk. In April 2017, Facebook was bragging at F8 about it’s brain-computer-interface research and the ability to type directly from the brain. The lines between when we are plugged “in” versus not will be increasingly blurred.

The right to mental integrity is already a recognized international law (Article 3 of the EU’s Charter of Fundamental Rights). The objective is to protect people against threats like “unwanted neurostimulation, malicious neurohacking and potentially harmful memory manipulation.”

The right to psychological continuity is a right that has been discussed more recently with the rise of cognitively manipulative digital content. It includes suggestions about how to deal with:

invasive marketing strategies such as those in which advertising is purposively designed to bypass a person’s rational defenses and alter their preferences or behavior

With the rise of any great technology, there is both good and bad. The benefits for neurotechnology for our society is enormous, and we’ll want to have the legal and ethical frameworks to guide its development.

Who is responsible for guiding this technological advancement?

Sometimes it’s obvious when we introduce something into the world that it will shift the paradigm (e.g., nuclear bombs or the internet), and with these shifts they were both often funded by governments and guided by policy (e.g., with nuclear came nuclear pacts). With the internet, the power of nation states has been changing, and that means other organizations are picking up the slack — take for example the rise of AI related tech which is largely privately funded rather than publicly developed.

Our government has been historically slow to think through and regulate emerging technologies, and independent citizens have come together to fill the gap. For example, OpenAI is a non-profit artificial intelligence research company that aims to carefully promote and develop friendly AI in such a way as to benefit humanity as a whole (editor’s note: written in 2017). OpenAI is supported by over US $1B in commitments by founders who are in part motivated by concerns about existential risk from AI intelligence.

As the power of the democratic nation state changes, the power of tech organizations rises and these non-governmental organizations are increasingly setting standards. But these organizations do not have any obligation to “the people” — is this a world we want to live in?

We are already seeing this shift happen in the autonomous car industry, where Google, Apple, Uber among others are setting the standards and ethics around life-and-death decisions for the car and its surroundings. How do we get in front of this for brain advancements?

Is all technological advancement good?

The duality of technology has been a part of human history for ages. With fire, we could warm villages and burn down cities. Nuclear power can provide electricity for billions and destroy nations.

Phillip Rogaway, Department of Computer Science, at UC Davis, wrote about technological optimism in his piece “The Moral Character of Cryptographic Work”:

Technological optimists believe that technology makes life better. According to this view, we live longer, have more freedom, enjoy more leisure. Technology enriches us with artifacts, knowledge, and potential. Coupled with capitalism, technology has become this extraordinary tool for human development. At this point, it is central to mankind’s mission. While technology does bring some unintended consequences, innovation itself will see us through.
Technological optimism animates everyone from school children to Turing Award winners. Accepting his 2012 Turing Award, Silvio Micali, said that
Computer science is marking an epical change in human history. We are conquering a new and vast scientific continent. . . . Virtually all areas of human activity . . . [and] virtually all areas of human knowledge . . . are benefiting from our conceptual and technical contributions. . . . Long live computer science!
If you’re a technological optimist, a rosy future flows from the wellspring of your work. This implies a limitation on ethical responsibility. The important thing is to do the work, and do it well. This even becomes a moral imperative, as the work itself is your social contribution.
But what if computer science is not benefiting man?

Our brain-related advances have the same conundrum. What are the technologies that we want to introduce into our world, and which ones do we want to avoid?

Many of the advancements are inevitabilities. If there is an incentive, it will happen. Change in policies and incentives can unleash massive changes in society (think Orphan Drug Act of 1983 and the impact on rare disease research). It will be useful to map out the likely inevitabilities for neurotech that we can identify today, and then really work through the incentives.

There is real danger in passively sitting back and watching our future shape us. We will have a much better society if we actively work through these questions, form opinions, build organizations (like the non-profit OpenAI intended to be and has since evolved), and hold our governments and institutions accountable to shaping our future.

Let’s lean in and build an intentional future; not an accidental one.

Acknowledgements: Big thanks to Brian Smith for kicking off this NeuroTech project with me many years ago, and for reviewing this post. To my editor Adam Conner-Simons, Owen McCarthy for the MedRhythms example, Greg Leppert and Dan Goodwin for reviewing very early drafts, and to my friends Jess Cole, Ginny Fahs, Rachel Katz, Linda Xie, and John Weldon who inspired me to resurrect this project out of my drafts and ship it!

<hr><p>Evolution of the Human Brain: The Past, The Now, and Our Future was originally published in Andrea’s Blog on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>